Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

12.5%

3 terminated/withdrawn out of 24 trials

Success Rate

78.6%

-7.9% vs industry average

Late-Stage Pipeline

33%

8 trials in Phase 3/4

Results Transparency

9%

1 of 11 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

Phase 3
7(29.2%)
Phase 2
6(25.0%)
Phase 1
6(25.0%)
N/A
4(16.7%)
Phase 4
1(4.2%)
24Total
Phase 3(7)
Phase 2(6)
Phase 1(6)
N/A(4)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (24)

Showing 20 of 24 trials
NCT07562191Phase 2Not Yet Recruiting

Inhaled DMT for Major Depressive Disorder

Role: collaborator

NCT06638931Phase 2Recruiting

Agnostic Therapy in Rare Solid Tumors

Role: collaborator

NCT07172724Phase 1Not Yet Recruiting

Clinical Trial to Evaluate the Safety and Immunogenicity of the Vivaxin Vaccine for Malaria Caused by Plasmodium Vivax."

Role: collaborator

NCT06719947Phase 2Not Yet Recruiting

HD-tDCS in Amyotrophic Lateral Sclerosis: A Multicenter Randomized Controlled Trial

Role: collaborator

NCT07037524Phase 1Not Yet Recruiting

Low Dose Radiotherapy for Heart Failure

Role: collaborator

NCT06970470Not ApplicableNot Yet Recruiting

Efficacy of Spinal Orthoses on Mobility in Older Adults With Hyperkyphosis

Role: collaborator

NCT05814432Phase 3Recruiting

Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS

Role: collaborator

NCT02691078Phase 2Completed

Validation of 99mTc- EDDA - HYNIC -TOC Kits for Diagnosis of Neuroendocrine Tumors

Role: collaborator

NCT06783478Phase 2Not Yet Recruiting

NK Cell Infusion for Remission Consolidation in AML: A Phase II Trial

Role: collaborator

NCT02270658Not ApplicableCompleted

Morbidity in Patients With Hypertension and Obstructive Sleep Apnea

Role: collaborator

NCT02532660Phase 3Terminated

Study to Evaluate the Efficacy of LABCAT TCJUSS in Patients With Depressive Episode

Role: collaborator

NCT04561219Phase 2Completed

Nitazoxanide Therapy for Patients With COVID-19 Pneumonia

Role: collaborator

NCT02056977Not ApplicableUnknown

PEEP Levels Selected by PEEP Titration and PEEP Levels Routinely Used in Post-operative Cardiac Patients With Hypoxemic Respiratory Failure

Role: collaborator

NCT00349271Phase 3Terminated

Cell Therapy in Chagas Cardiomyopathy

Role: collaborator

NCT00333827Phase 3Completed

Cell Therapy In Dilated Cardiomyopathy

Role: collaborator

NCT01154049Phase 1Completed

Study to Evaluate the Safety of the Vaccine Prepared sm14 Against Schistosomiasis

Role: collaborator

NCT02818803Phase 3Completed

Efficacy of Standardized-propolis Extract (EPP-AF®) Gel Formulation as Buccal Antiseptic

Role: collaborator

NCT02418676Phase 1Completed

Insulin Complexation With Hydroxypropyl-beta-cyclodextrin: Use of the Complex in Gel for Healing of Pressure Ulcers

Role: collaborator

NCT00656721Not ApplicableCompleted

Respiratory Mechanics Effects of Flutter Valve in Bronchiectasis Patients

Role: collaborator

NCT00971165Phase 3Completed

Diuretics and Angiotensin-Receptor Blocker Agents in Patients With Stage I Hypertension

Role: collaborator